Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-13

Clinical Trial Update: Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of combined resveratrol and myo-inositol on metabolic, endocrine parameters and perceived stress in polycystic ova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Myo-inositol (myo-inositol)
  • Resveratrol (resveratrol)

Snippet

Sponsor: Khyber Medical University Peshawar | Conditions: PCOS | Phase 2 | Status: COMPLETED